Back to the Roots: Safety and Tolerability of Standardised Ashwagandha Root Extract
Coope et al. · Pharmaceuticals
Ingredient / claim relationships
Public study database · v2026.08.16
Explore the structured studies attached to currently indexable ingredient profiles, including study class, sample size, dose, duration, population, outcome, limitations, safety reporting, and whether a source supports, complicates, or contradicts a claim context.
Structured studies
922
Human evidence sources
282
Human trials
110
Mixed/discordant entities
0
922 studies match
Coope et al. · Pharmaceuticals
Ingredient / claim relationships
Bashatwah RM et al. · Nutrients
Ingredient / claim relationships
Ingredient / claim relationships
Wang DD et al. · Pharmacol Res
Ingredient / claim relationships
Yang F et al. · Animal Model Exp Med
Ingredient / claim relationships
Ingredient / claim relationships
Feng Y et al. · Plant Physiol Biochem
Ingredient / claim relationships
Landells I et al. · J Cutan Med Surg
Ingredient / claim relationships
Zhang A et al. · J Pak Med Assoc
Ingredient / claim relationships
Mendonça D et al. · Pharmaceuticals (Basel)
Ingredient / claim relationships
Zhao Y et al. · Vet Microbiol
Ingredient / claim relationships
Zhang H et al. · Virol J
Ingredient / claim relationships
Caballero-Gallardo K et al. · Plants (Basel)
Ingredient / claim relationships
Li Q et al. · Autophagy
Ingredient / claim relationships
Tan X et al. · J Nanobiotechnology
Ingredient / claim relationships
Li H et al. · Compr Rev Food Sci Food Saf
Ingredient / claim relationships
García-Rodríguez C et al. · Biol Res
Ingredient / claim relationships
Ingredient / claim relationships
Wang X et al. · Phytomedicine
Ingredient / claim relationships
Qi Y et al. · Phytomedicine
Ingredient / claim relationships
PubMed · Osteoarthritis Cartilage
Ingredient / claim relationships
Gökçen EN et al. · Int J Mol Sci
Ingredient / claim relationships
Ingredient / claim relationships
Capasso L et al. · Molecules
Ingredient / claim relationships
Lei SS et al. · Mol Med
Ingredient / claim relationships
Qi X et al. · Metab Brain Dis
Ingredient / claim relationships
Li et al. · Phytotherapy Research
Ingredient / claim relationships
Derosa G et al. · Eur Rev Med Pharmacol Sci
Ingredient / claim relationships
Lei X et al. · Phytomedicine
Ingredient / claim relationships
Cui Q et al. · Sci Rep
Ingredient / claim relationships
Wei W et al. · Br J Pharmacol
Ingredient / claim relationships
Farag M et al. · J Huntingtons Dis
Ingredient / claim relationships
Otsuki K et al. · Plants (Basel)
Ingredient / claim relationships
Li X et al. · Mediators Inflamm
Ingredient / claim relationships
Ingredient / claim relationships
Aimjongjun S et al.
Ingredient / claim relationships
Aktaş E et al. · CNS Neurosci Ther
Ingredient / claim relationships
Wang Y et al. · Front Pharmacol
Ingredient / claim relationships
PubMed · Nat Sci Sleep
Ingredient / claim relationships
Todorova V et al. · Int J Mol Sci
Ingredient / claim relationships
Sakamoto S et al. · J Nat Med
Ingredient / claim relationships
Ingredient / claim relationships
Zhang Y et al. · Phytomedicine
Ingredient / claim relationships
Ciprandi G et al. · Minerva Pediatr (Torino)
Ingredient / claim relationships
Zhao X et al. · Int J Mol Sci
Ingredient / claim relationships
Tepper SJ et al. · Curr Pain Headache Rep
Ingredient / claim relationships
Muhammed Saeed AA et al. · J Health Popul Nutr
Ingredient / claim relationships
Somma F et al. · Biomed Pharmacother
Ingredient / claim relationships
He S et al. · Chin Herb Med
Ingredient / claim relationships
Liu J et al. · Front Pharmacol
Ingredient / claim relationships
Dataset citation
The Hippie Scientist. The Hippie Scientist Public Evidence Dataset 2026. Version 2026.08.16. https://thehippiescientist.net/evidence/evidence-report/
Stable study IDs prefer PMID, then DOI, then source URL, then a normalized title fallback. Ingredient relationships are represented separately from study identity so the same paper can be interpreted in more than one ingredient or outcome context without duplicating the paper itself.
Those labels describe how a structured study relationship is used for a particular ingredient or claim context. They are kept separate so conflicting evidence is visible instead of averaged away.
No. Study design, sample size, population, dose, formulation, outcome, limitations, replication, and disagreement with other studies all affect confidence. The explorer exposes those details rather than treating citation count as proof.
They can be useful research context and help explain plausibility, but the explorer labels them separately from direct human evidence so they are not mistaken for clinical efficacy evidence.
Learning context
Search and filter the trials, reviews, observational studies, preclinical sources, doses, populations, outcomes, limitations, and evidence directions… Learning pages explain the reasoning layer behind the herb and compound library. They are designed to make mechanisms, evidence quality, safety tradeoffs, and product claims easier to interpret.
Use Search the evidence behind the ingredient profiles. to build better questions before choosing a supplement: what outcome is being targeted, what mechanism is claimed, what human evidence exists, what dose was studied, and what risks could change the answer for a specific person?
Mechanistic plausibility is useful, but it should be weighed against trial design, safety history, product quality, and the possibility that a simpler intervention may be more appropriate.